Gc Biopharma USA, Inc.

Overview

GC Biopharma USA produces high-quality plasma-derived medicines, including ALYGLO, dedicated to improving patient health and well-being.

Classification

This U.S. industry comprises establishments primarily engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations (except biological) intended for internal and external consumption in dose forms, such as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions.

1. Manufacturing32
2. Chemical Manufacturing325
3. Pharmaceutical and Medicine Manufacturing32541
4. Pharmaceutical Preparation Manufacturing325412

Capabilities

Federal awards